Pfizer, La. End Neurontin Antitrust Suit With $1M In Naloxone

Law360, New York (May 17, 2017, 5:59 PM EDT) -- Pfizer Inc. has agreed to provide Louisiana first responders with $1 million worth of the opioid overdose treatment naloxone in exchange for the state dropping its allegations that Pfizer used sham patent litigation to keep a generic version of its anticonvulsant Neurontin off the market.

The unusual settlement will end antitrust litigation filed in Louisiana state court. Pfizer will provide vouchers to agencies who request them from the state justice department, which can then be exchanged for the free naloxone at local pharmacies, state prosecutors said...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.